Vivek Roy

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer journal

Case reports in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Sikandar Ailawadhi, Yaw Adu, Ryan D Frank, Saurav Das, David O Hodge, Andre Fernandez, Caitlyn Flott, Jamie Elliott, Ricardo D Parrondo, Taimur Sher, Vivek Roy, Asher A Chanan-Khan
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities. Blood cancer journal 14 (1) (2024)
Sikandar Ailawadhi, Yaw Adu, Ryan D Frank, Saurav Das, David O Hodge, Andre Fernandez, Caitlyn Flott, Jamie Elliott, Ricardo D Parrondo, Taimur Sher, Vivek Roy, Asher A Chanan-Khan
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities. Blood cancer journal 14 (1) (2024)
Sikandar Ailawadhi, Yaw Adu, Ryan D Frank, Saurav Das, David O Hodge, Andre Fernandez, Caitlyn Flott, Jamie Elliott, Ricardo D Parrondo, Taimur Sher, Vivek Roy, Asher A Chanan-Khan
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities. Blood cancer journal 14 (1) (2024)
Ricardo D Parrondo, Betsy R LaPlant, Jamie Elliott, Andre Fernandez, Caitlin J Flott, Diedre Arrington, Dustin Chapin, Jade Brown, Saurav Das, Vivek Roy, Asher A Chanan-Khan, Sikandar Ailawadhi
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood cancer journal 14 (1) (2024)
Nadine H Abdallah, Thomas E Witzig, Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, Angela Dispenzieri, Vivek Roy, Morie A Gertz, Peter Leif Bergsagel, Sundararajan Vincent Rajkumar
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up. Leukemia 38 (5) (2024)
Nadine H Abdallah, Thomas E Witzig, Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, Angela Dispenzieri, Vivek Roy, Morie A Gertz, Peter Leif Bergsagel, Sundararajan Vincent Rajkumar
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up. Leukemia 38 (5) (2024)
Sikandar Ailawadhi, Yaw Adu, Ryan D Frank, Saurav Das, David O Hodge, Andre Fernandez, Caitlyn Flott, Jamie Elliott, Ricardo D Parrondo, Taimur Sher, Vivek Roy, Asher A Chanan-Khan
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities. Blood cancer journal 14 (1) (2024)
Nadine H Abdallah, Thomas E Witzig, Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, Angela Dispenzieri, Vivek Roy, Morie A Gertz, Peter Leif Bergsagel, Sundararajan Vincent Rajkumar
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up. Leukemia (2024)
Sikandar Ailawadhi, Yaw Adu, Ryan D Frank, Saurav Das, David O Hodge, Andre Fernandez, Caitlyn Flott, Jamie Elliott, Ricardo D Parrondo, Taimur Sher, Vivek Roy, Asher A Chanan-Khan
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities. Blood cancer journal 14 (1) (2024)
Sikandar Ailawadhi, Yaw Adu, Ryan D Frank, Saurav Das, David O Hodge, Andre Fernandez, Caitlyn Flott, Jamie Elliott, Ricardo D Parrondo, Taimur Sher, Vivek Roy, Asher A Chanan-Khan
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities. Blood cancer journal 14 (1) (2024)
Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia T Greipp, Rhett P Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafael Fonseca, Peter Leif Bergsagel, Sikander Ailawadhi, Vivek Roy, Ricardo D Parrondo, Taimur Sher, Suzanne R Hayman, Prashant Kapoor, Nelson R Leung, Joselle Madonna Cook, Moritz Binder, Eli Muchtar, Rahma M Warsame, Taxiarchis V Kourelis, Ronald S Go, Yi Lin, Abhishek Seth, Scott C Lester, William G Breen, Robert A Kyle, Morie A Gertz, S Vincent Rajkumar, Wilson I Gonsalves
Impact of Cytogenetic Abnormalities on the Risk of Disease Progression in Solitary Bone Plasmacytomas. Blood (2023)
Farah Yassine, Mohamed A Kharfan-Dabaja, Athanasios Tsalantsanis, Vivek Roy, Abba C Zubair, Hemant S Murthy, Ernesto Ayala, Madiha Iqbal, Taimur Sher, Sikandar Ailawadhi, Ricardo D Parrondo
Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience. Bone marrow transplantation (2023)
Ricardo D Parrondo, Keren Sam, Ahsan Rasheed, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan-Khan, Sikandar Ailawadhi
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. Blood cancer journal 12 (4) (2022)
Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, Mikolaj Wieczorek, Liuyan Jiang, Hassan B Alkhateeb, Mark R Litzow, Patricia Greipp, Taimur Sher, Peter Leif Bergsagel, Rafael Fonseca, Vivek Roy, Angela Dispenzieri, Mohamed A Kharfan-Dabaja, Hemant S Murthy, Sikandar Ailawadhi, James M Foran
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma. Blood cancer journal 12 (6) (2022)
Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Peter Leif Bergsagel, Moritz Binder, Asher A Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A Gertz, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Taxiarchis V Kourelis, Martha Q Lacy, Nelson R Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma M Warsame, Amie L Fonder, Miriam Hobbs, Yi L Hwa, Robert A Kyle, S Vincent Rajkumar, Shaji K Kumar
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance. Blood 140 (18) (2022)
Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikandar Ailawadhi, Jeremy Larsen, Peter Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A Gertz, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Taxiarchis V Kourelis, Martha Q Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma Warsame, Amie Fonder, Miriam Hobbs, Yi L Hwa, Robert A Kyle, Sundararajan Vincent Rajkumar, Shaji K Kumar
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy. Blood cancer journal 12 (11) (2022)
Ricardo D Parrondo, Vivek Roy, Taimur Sher, Victoria Alegria, Asher A Chanan-Khan, Sikandar Ailawadhi
Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review. Case reports in hematology 2020 (2020)
Sharad Khurana, Manuel Beltran, Liuyan Jiang, Ernesto Ayala, Vivek Roy
Primary Cutaneous T-Cell Lymphoblastic Lymphoma: Case Report and Literature Review. Case reports in hematology 2019 (2019)